Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2026 10:08 ET | Source: Fédération Internationale de l'Automobile

FIA Delivers Strongest Set of Financial Results in a Decade

FIA posts best financial results in a decade: €6.7M operating profit in 2025, revenues of €191.7M, and cash doubled to €43.6M
June 24, 2026 16:01 ET | Source: Micron Technology, Inc.

Micron Technology, Inc. Reports Record Results for the Third Quarter of Fiscal 2026

BOISE, Idaho, June 24, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its third quarter of fiscal 2026, which ended May 28, 2026. Fiscal Q3 2026...
June 15, 2026 06:33 ET | Source: Bleichmar Fonti & Auld

MAX Shareholder News: MediaAlpha Investors may have Rights in Investigation over FTC Settlement – Current Shareholders Urged to Contact BFA Law

MediaAlpha Investors may have Rights in Investigation over FTC Settlement – Current Shareholders Urged to Contact BFA Law
May 26, 2026 07:00 ET | Source: Westhaven Gold Corp.

Westhaven Reports 8.12m Grading 47.56 g/t Gold and 229 g/t Silver from Resource Infill Drilling at the Shovelnose Property, Southern British Columbia

High-grade results at South Zone; 8.12m grading 47.56 g/t Au and 229 g/t Ag within a 33.0m interval grading 14.00 g/t Au and 78 g/t Ag. Broad, consistent mineralization intersected, including 24.63m...
May 22, 2026 06:47 ET | Source: Bleichmar Fonti & Auld

WIX Inquiry News: Wix Investors are Notified of BFA Law’s Ongoing Investigation into the Company’s Potential Misstatements – Contact the Firm if You Lost Money

Wix Investors are Notified of BFA Law’s Ongoing Investigation into the Company’s Potential Misstatements – Contact the Firm if You Lost Money
May 22, 2026 01:30 ET | Source: OSE Immunotherapeutics

OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer

OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer
May 22, 2026 01:30 ET | Source: OSE Immunotherapeutics

OSE Immunotherapeutics annonce les résultats de Topline positifs de l'étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire en rechute

Les résultats de Topline seront présentés par le Pr Alexandra Leary, PhD, le 30 mai 2026 au congrès annuel de l’American Society of Clinical Oncology (ASCO) à ChicagoOSE Immunotherapeutics organisera...
May 20, 2026 07:00 ET | Source: 4basebio

Final Results and Notice of AGM

CAMBRIDGE, UK – 20 May 2026 – 4basebio plc (AIM: 4BB), a company pioneering an enzymatically-produced DNA technology serving the next generation genetic medicines markets, announces its audited final...
May 20, 2026 06:18 ET | Source: Bleichmar Fonti & Auld

WIX Securities Investigation: Wix 27% Stock Drop Triggers Securities Fraud Investigation Over AI-Demand Issues – Investors Urged to Contact BFA Law

Wix 27% Stock Drop Triggers Securities Fraud Investigation Over AI-Demand Issues – Investors Urged to Contact BFA Law
May 19, 2026 11:40 ET | Source: Aedifica

Aedifica NV/SA: Interim financial report – Q1 2026

Please find below Aedifica’s interim financial report for the 1st quarter of the 2026 financial year. Creating Europe’s leading healthcare REIT Aedifica acquired control over Cofinimmo on 10 March...